Orthofix Medical Inc. announced the appointment of Michael Finegan as Chair of the Board of Directors. Finegan was appointed to the Orthofix Board in December 2023. He is CEO at Acera Surgical, a bioscience company developing and commercializing a portfolio of fully engineered synthetic materials for soft tissue repair and regenerative medicine.

Prior to joining Acera, Finegan spent 14 years at Orthofix where he served in roles of increasing responsibility, including seven years as Chief Strategy Officer. Prior to Finegan?s tenure at Orthofix, he served more than 16 years in a variety of roles at Boston Scientific. Finegan has a BA in economics from Wake Forest University.